BioAegis Therapeutics, Inc. — Form D/A
BioAegis Therapeutics, Inc. of Morristown, NJ, a company, filed a Form D amendment with the SEC on 2013-02-08. The offering totals $6.0M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-02-08
- Form: D/A
- Accession: 0001546604-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $3.1M
- Remaining: $2.9M
- Investors: 42
- Date of first sale: 2012-03-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-176500
Issuer
- Name: BioAegis Therapeutics, Inc.
- CIK: 0001546604
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 6 East Cove Lane, Morristown, NJ, 07960
- Phone: 973-539-4552
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Valerie Ceva | Director | Morristown, NJ |
| Valerie Ceva | Executive Officer | Morristown, NJ |
| Mark DiNubile | Director | Morristown, NJ |
| Mark DiNubile | Executive Officer | Morristown, NJ |
| Susan Levinson | Director | Morristown, NJ |
| Susan Levinson | Executive Officer | Morristown, NJ |
| John Stossel | Director | Morristown, NJ |
| Thomas Stossel | Director | North Brunswick, NJ |
| Thomas Stossel | Executive Officer | North Brunswick, NJ |
| Steven Cordovano | Executive Officer | North Brunswick, NJ |
| Steve Cordovano | Executive Officer | Morristown, NJ |
| Susan L Levinson | Director | Morristown, NJ |
| Susan L Levinson | Executive Officer | Morristown, NJ |
| Valerie L Ceva | Director | New York, NY |
| Valerie L Ceva | Executive Officer | New York, NY |
| Thomas L Stossel | Director | Belmont, MA |
| Steven L Cordovano | Executive Officer | Rowayton, CT |
Other filings by this issuer (8)
More